Ning Sheng

机构：Zaozhuang Municipal Hospital, Guizhou Provincial People's Hospital · ORCID：0000-0002-3308-3960

发表论文 44 篇 · 总被引 1241 次 · h-index 16

代表论文

• Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients (2021 · Signal Transduction and Targeted Therapy · 被引 211)
• Caffeic acid alleviates cerebral ischemic injury in rats by resisting ferroptosis via Nrf2 signaling pathway (2023 · Acta Pharmacologica Sinica · 被引 96)
• Scutellarin Rescued Mitochondrial Damage through Ameliorating Mitochondrial Glucose Oxidation via the Pdk‐Pdc Axis (2023 · Advanced Science · 被引 51)
• 4,5 caffeoylquinic acid and scutellarin, identified by integrated metabolomics and proteomics approach as the active ingredients of Dengzhan Shengmai, act against chronic cerebral hypoperfusion by regulating glutamatergic and GABAergic synapses (2020 · Pharmacological Research · 被引 45)
• Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma (2019 · Journal of Cellular Physiology · 被引 34)
• Impaired tricarboxylic acid cycle flux and mitochondrial aerobic respiration during isoproterenol induced myocardial ischemia is rescued by bilobalide (2020 · Journal of Pharmaceutical Analysis · 被引 28)